Biomarkers in fever and neutropenia: A solution in search of a problem?

Critical Care Medicine

Volumn 39, Issue 5, 2011, Pages 1205-1206

  Gea Banacloche, Juan ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

biomarkers; febrile neutropenia; fever; granulocytopenia; interleukin 8; procalcitonin; sTREM 1

Indexed keywords

BIOLOGICAL MARKER; GALACTOMANNAN; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

BACTERIAL INFECTION; EDITORIAL; FEBRILE NEUTROPENIA; HIGH RISK PATIENT; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; UPREGULATION;

EID: 79955368546     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31820f6d6d     Document Type: Editorial

References (18)

1. Schimpff S, Satterlee W, Young VM, et al: Empiric therapy with carbenicillin and gen-tamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971; 284: 1061-1065
2. Hughes WT, Armstrong D, Bodey GP, et al: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-751 (Pubitemid 34194843)
3. Bucaneve G, Micozzi A, Menichetti F, et al: Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 2005; 353:977-987 (Pubitemid 41262332)
4. El-Maghraby SM, Moneer MM, Ismail MM, et al: The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neu-tropenic children with hematologic malig-nancies. J Pediatr Hematol Oncol 2007; 29: 131-136 (Pubitemid 46673396)
5. Oude Nijhuis C, Kamps WA, Daenen SMG, et al: Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol 2005; 23:7437-7444 (Pubitemid 46291805)
6. Prat C, Sancho JM, Dominguez J, et al: Eval-uation ofprocalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutro-penia. Leuk Lymphoma 2008; 49:1752-1761
7. Lin C-H, Yao M, Hsu S-C, et al: Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever. Crit Care Med 2011; 39:993-999
8. Miedema KGE, de Bont ESJM, Elferink RFMO, et al: The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial in-fections in pediatric oncology patients with fe-brile neutropenia. Support Care Cancer 2010 Aug 28 [Epub ahead of print]
9. Bouchon A, Dietrich J, Colonna M: Cutting edge: Inflammatory responses can be trig-gered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000; 164:4991-4995 (Pubitemid 30305166)
10. Gibot S, Cravoisy A, Levy B, et al: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. NEngl J Med 2004; 350:451-458 (Pubitemid 38133765)
11. Gibot S, Cravoisy A, Kolopp-Sarda MN, et al: Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, pro-calcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 2005; 33:792-796
12. Barati M, Bashar FR, Shahrami R, et al: Sol-uble triggering receptor expressed on my-eloid cells 1 and the diagnosis of sepsis. J Crit Care 2010; 25:362.e361-362.e366
13. Bopp C, Hofer S, Bouchon A, et al: Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsur-vivors in the early stage of acute inflamma-tion. Eur J Anaesthesiol 2009; 26:504-507
14. Latour-Pérez J, Alcalá-López A, García- García M-A, et al: Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory re-sponse syndrome. Clin Biochem 2010; 43: 720-724
15. Segal BH, Freifeld AG, Baden LR, et al: Pre-vention and treatment of cancer-related in-fections. J Natl Compr Canc Netw 2008; 6:122-174
16. Maertens J, Theunissen K, Verhoef G, et al: Galactomannan and computed tomography-based preemptive antifungal therapy in neu-tropenic patients at high risk for invasive fungal infection: A prospective feasibility study. Clin Infect Dis 2005; 41:1242-1250 (Pubitemid 41534660)
17. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al: Multicenter clinical evaluation of the (1-<3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41:654-659 (Pubitemid 41170353)
18. Sakr Y, Sponholz C, Tuche F, et al: The role of procalcitonin in febrile neutropenic pa-tients: Review of the literature. Infection 2008; 36:396-407